Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method and process of compound paclitaxel anti-leukemia capsule tablet

A production method and technology of paclitaxel, which are applied in capsule delivery, anti-tumor drugs, drug combination and other directions, can solve the problems of high recurrence probability, large toxic and side effects of radiotherapy and chemotherapy, strong rejection reaction, etc., and achieve the effect of regulating the spleen and stomach. The effect of enhancing specific immunity and reducing symptoms

Pending Publication Date: 2022-04-12
庞作仁
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In recent years, although there have been many effective methods for the treatment of leukemia, and some clinical results have been obtained, there are also many disadvantages, such as: radiotherapy and chemotherapy have high toxicity and side effects, which often cause many complications and bring unnecessary pain to patients. ; Although bone marrow transplantation can save the lives of patients, it is difficult to match the bone marrow, and the rejection reaction is relatively strong. Many leukemia patients often die from the above reasons; after many patients take anti-leukemia chemotherapy drugs, their condition has been partially relieved or Controlled, but chances of recurrence remain high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and process of compound paclitaxel anti-leukemia capsule tablet

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0027] Unless otherwise defined, the technical terms used in the following embodiments have the same meaning as commonly understood by those skilled in the art to which the present invention belongs.

[0028] The present invention will be described in detail below.

[0029] The preparation method and process of the compound paclitaxel anti-leukemia capsule tablet, the drug composition of the compound paclitaxel anti-leukemia capsule tablet for acute lymphoblastic leukemia is as follows: astragalus, codonopsis, licorice, asparagus, sunburned polygonatum, medlar, angelica, peony root, crane Grass, Eclipta, Imperatae Root, Comfrey, Scrophulariaceae, Radix Isatidis, Folium Isatidis, Poppy Shell, Gypsum, Tiger Eye Echinacea Saponins, Papaya Alkaloids, Antrodia Polysaccharide with Immunity Enhancement, Superoxide Dismutation Enzyme SOD, Gynostemma pentaphyllum, compound paclitaxel; the compound paclitaxel anti-leukemia capsule tablet for chronic myeloid leukemia drug combination is ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a preparation method and process of a compound paclitaxel anti-leukemia capsule tablet. The compound paclitaxel anti-leukemia capsule tablet is prepared from the following medicinal compositions aiming at acute lymphocytic leukemia: astragalus membranaceus, codonopsis pilosula, liquorice, asparagus cochinchinensis, roasted rhizoma polygonati, fructus lycii, angelica sinensis, radix paeoniae alba, hairyvein agrimony, eclipta alba, lalang grass rhizome, lithospermum, radix scrophulariae, isatis root, folium isatidis, pericarpium papaveris, gypsum, ornithogalum caudatum saponin, papaya alkaloid and antrodia camphorata polysaccharide. The composition is prepared from the following raw materials: SOD, fiveleaf gynostemma herb and compound paclitaxel. The agent A and the agent B contain various compounds such as saponins, terpenoids, alkaloids, flavonoids, sterols and polysaccharides, drug molecules are micronized and can be fully absorbed and utilized after the agent A and the agent B are prepared through magnetized water and ultrasonic oscillation, and under the synergistic effect of all the drugs, the effects of clearing away heat and toxic materials, cooling blood, nourishing yin, promoting salivation, stopping bleeding and regulating the spleen and the stomach are outstanding, the effect is fast, and the treatment effect is good. The symptom can be relieved after the medicine is taken for 1 hour.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a preparation method and technology of compound paclitaxel anti-leukemia capsule tablets. Background technique [0002] Leukemia is a malignant clonal disease of hematopoietic stem cells. Clonal leukemia cells proliferate and accumulate in bone marrow and other hematopoietic tissues due to mechanisms such as uncontrolled proliferation, differentiation disorder, and apoptosis inhibition, and infiltrate other non-hematopoietic tissues and organs, while inhibiting normal hematopoietic function. Clinically, different degrees of anemia, hemorrhage, infection, fever, enlargement of liver, spleen, lymph nodes and bone pain can be seen. [0003] In recent years, although there have been many effective methods for the treatment of leukemia, and some clinical results have been obtained, there are also many disadvantages, such as: radiotherapy and chemothe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/44A61K9/48A61P35/02A61K36/899A61K33/06A61K31/704A61K31/715A61K31/337A61K36/8945A61K35/36A61K35/618A61K35/586A61K35/57
Inventor 庞作仁李恩荣杨贵修王明会刘东庞中龙杨忠荣
Owner 庞作仁
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products